BlackRock Advisors’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $39K | Sell |
143
-20
| -12% | -$5.46K | ﹤0.01% | 3233 |
|
|
2016
Q3 | $64K | Buy |
163
+29
| +22% | +$11.4K | ﹤0.01% | 3110 |
|
|
2016
Q2 | $47K | Buy |
134
+29
| +28% | +$10.2K | ﹤0.01% | 3189 |
|
|
2016
Q1 | $88K | Hold |
105
| – | – | ﹤0.01% | 2924 |
|
|
2015
Q4 | $110K | Sell |
105
-43
| -29% | -$45K | ﹤0.01% | 2836 |
|
|
2015
Q3 | $116K | Sell |
148
-2
| -1% | -$1.57K | ﹤0.01% | 2988 |
|
|
2015
Q2 | $197K | Buy |
150
+64
| +74% | +$84.1K | ﹤0.01% | 2759 |
|
|
2015
Q1 | $174K | Buy |
86
+12
| +16% | +$24.3K | ﹤0.01% | 2730 |
|
|
2014
Q4 | $142K | Sell |
74
-1,576
| -96% | -$3.02M | ﹤0.01% | 2814 |
|
|
2014
Q3 | $1.35M | Sell |
1,650
-192
| -10% | -$157K | ﹤0.01% | 1270 |
|
|
2014
Q2 | $1.78M | Buy |
1,842
+3
| +0.2% | +$2.89K | ﹤0.01% | 1180 |
|
|
2014
Q1 | $1.99M | Buy |
1,839
+582
| +46% | +$630K | ﹤0.01% | 1158 |
|
|
2013
Q4 | $1.11M | Buy |
1,257
+1,215
| +2,893% | +$1.08M | ﹤0.01% | 1422 |
|
|
2013
Q3 | $47K | Buy |
42
+5
| +14% | +$5.6K | ﹤0.01% | 3193 |
|
|
2013
Q2 | $44K | Buy |
+37
| New | +$44K | ﹤0.01% | 3186 |
|